BIA 9-1067 5 mg

DRUG2 trials

Sponsors

Bial - Portela C S.A.

Conditions

Parkinson DiseaseParkinson's Disease (PD)

Phase 1

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

CompletedNCT01519284

Bial - Portela C S.A.Parkinson Disease

Start: 2009-11-30End: 2011-06-30Updated: 2015-08-20

Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics

CompletedNCT02169414

Bial - Portela C S.A.Parkinson's Disease (PD)

Start: 2010-02-28End: 2010-07-31Updated: 2015-12-24